documents: FDA-2022-N-2390-0161
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-2390-0161 | FDA | FDA-2022-N-2390 | Notice of the Denial of a Hearing Request Regarding a Proposal To Refuse To Approve a Supplemental New Drug Application for HETLIOZ (Tasimelteon) | Notice | Notice of Denial | 2025-03-07T05:00:00Z | 2025 | 3 | 2025-03-07T05:00:00Z | 2025-03-07T14:52:35Z | 2025-03697 | 0 | 0 | 09000064869b9231 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref